These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34065672)

  • 1. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
    Henkhaus RS; Gerner EW; Ignatenko NA
    Biol Chem; 2008 Jun; 389(6):757-64. PubMed ID: 18627290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
    Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
    Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
    Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
    Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
    Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM
    Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical pathways mediated by KLK6 protease in breast cancer.
    Pampalakis G; Zingkou E; Sidiropoulos KG; Diamandis EP; Zoumpourlis V; Yousef GM; Sotiropoulou G
    Mol Oncol; 2019 Nov; 13(11):2329-2343. PubMed ID: 30980596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLK10 promotes the progression of KRAS mutant colorectal cancer via PAR1-PDK1-AKT signaling pathway.
    Wu K; Wu B; Yan K; Ding Q; Miao Z
    Cell Biol Int; 2024 Apr; 48(4):440-449. PubMed ID: 38115179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.
    Ohlsson L; Lindmark G; Israelsson A; Palmqvist R; Öberg Å; Hammarström ML; Hammarström S
    Br J Cancer; 2012 Jun; 107(1):150-7. PubMed ID: 22699826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
    Ahmed N; Dorn J; Napieralski R; Drecoll E; Kotzsch M; Goettig P; Zein E; Avril S; Kiechle M; Diamandis EP; Schmitt M; Magdolen V
    Biol Chem; 2016 Dec; 397(12):1265-1276. PubMed ID: 27483364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
    Malki A; ElRuz RA; Gupta I; Allouch A; Vranic S; Al Moustafa AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
    Dong S; Ding Z; Zhang H; Chen Q
    Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.